IL-12N220L, N-glycosylation mutant of IL-12, shows more potent anti-tumor effets than its wild-type in gene-based immunotherapy and the effects are augmented by combination with anti-angiogenic peptid
- Title
- IL-12N220L, N-glycosylation mutant of IL-12, shows more potent anti-tumor effets than its wild-type in gene-based immunotherapy and the effects are augmented by combination with anti-angiogenic peptid
- Authors
- 성영철
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/87242
- Article Type
- Conference
- Citation
- Keystone Symposia (Rational design of vaccines and immunotherapeutics(A2))
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.